Related Experiment Video
Updated: Jul 4, 2026
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Acamprosate: recent findings and future research directions
Karl Mann1, Falk Kiefer, Rainer Spanagel
1The Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health University of Heidelberg, Mannheim, Germany.
Alcoholism, Clinical and Experimental Research
|June 11, 2008
Summary
Acamprosate helps prevent alcoholism relapse by reducing brain glutamate levels, particularly in "relief cravers." Further research aims to define specific patient subgroups for personalized treatment strategies.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Medicine
Background:
- Alcoholism relapse is a significant challenge in addiction treatment.
- Acamprosate is a medication used for alcohol dependence relapse prevention.
- Existing understanding of acamprosate's mechanism of action is incomplete.
Purpose of the Study:
- To explore the molecular mechanisms of acamprosate's efficacy in preventing alcoholism relapse.
- To identify potential responder profiles for acamprosate treatment.
- To investigate the role of glutamatergic systems in alcohol dependence and treatment response.
Main Methods:
- Review of molecular and cellular evidence on acamprosate's action.
- Analysis of studies involving mutant mice with altered glutamate levels.
- Examination of animal models for cue-induced relapse behaviors.
- Overview of the ongoing "Project Predict" study defining patient profiles (reward vs. relief cravers) using neurophysiological and psychometric data.
Main Results:
- Acamprosate attenuates hyper-glutamatergic states during early abstinence, involving NMDA and mGluR5 glutamate receptors.
- Mutant mice with higher glutamate levels show increased alcohol consumption and better response to acamprosate.
- Acamprosate reduces cue-induced reinstatement behavior in rats but may not affect cue-induced craving in alcohol-dependent patients.
- Preliminary data suggests acamprosate may be more effective in "relief cravers" experiencing withdrawal-associated hyper-glutamatergic states.
Conclusions:
- Acamprosate primarily acts on the hyper-glutamatergic system, suggesting neuroprotective properties.
- Individualized treatment strategies, like those in "Project Predict," are crucial for optimizing acamprosate and naltrexone use.
- Further research using endophenotypic approaches, such as MR spectroscopy, is needed to define specific patient subgroups and hyper-glutamatergic syndromes.
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...